文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Antidepressants vs. Placebo for the Treatment of Functional Gastrointestinal Disorders in Adults: A Systematic Review and Meta-Analysis.

作者信息

Xiong Nana, Duan Yanping, Wei Jing, Mewes Ricarda, Leonhart Rainer

机构信息

Department of Psychological Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China.

Department of Psychology, University of Vienna, Vienna, Austria.

出版信息

Front Psychiatry. 2018 Dec 4;9:659. doi: 10.3389/fpsyt.2018.00659. eCollection 2018.


DOI:10.3389/fpsyt.2018.00659
PMID:30564156
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6288425/
Abstract

To integrate high-quality evidence of the efficacy of antidepressants across different subtypes of functional gastrointestinal disorders (FGIDs). The Medline, PsycINFO, EMBASE, the Cochrane Library, and Chinese local database were searched up to October 1, 2017. Keywords included all subtypes of FGIDs, antidepressants, and randomized controlled trials (RCTs). We included RCTs with low to moderate risks of bias in comparing antidepressants with placebos as the only intervention in treating adult patients with FGIDs (PROSPERO ID: CRD42015030123). Language was restricted to English or Chinese. Data extraction was independently carried out by two authors, following the Cochrane Handbook for systematic reviews. Of 2,460 records identified, 31 studies reporting on 2,340 participants were included in the meta-analysis. Antidepressants were more effective than placebos in terms of the rate of responder [RR = 1.35 (95% CI 1.12 to 1.63)], and the reduction of target gastrointestinal symptoms [SMD = -0.94 (95% CI -1.33 to -0.54)], and disability severity (moderate effect sizes). Those effects partly remained both at the presence and absence of comorbid depression, and among different subtypes of FGIDs. Subgroup analyses confirmed the benefit of tricyclic and tetracyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs), and trazodone. Efficacy of serotonin and norepinephrine reuptake inhibitors (SNRIs), low doses of antidepressants, and antidepressants in intermediate to long term treatment was inconclusive due to the scarcity of eligible evidence. Compared to placebo, patients on antidepressants reported more adverse events [RR = 1.91 (95% CI 1.23 to 2.96)] and more frequent withdrawal. On average one in 7.4 (95% CI 5.4 to 11.9) patients treated with antidepressants responded, while one in 4.8 (95% CI 3.7 to 6.8) experienced certain adverse effects. Antidepressants were inferior to placebo in terms of tolerability and partly superior regarding efficacy. Before prescribing antidepressants, the benefits and side effects should be carefully evaluated.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4120/6288425/490ef8e1adf4/fpsyt-09-00659-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4120/6288425/590d2b0f0cf0/fpsyt-09-00659-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4120/6288425/490ef8e1adf4/fpsyt-09-00659-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4120/6288425/590d2b0f0cf0/fpsyt-09-00659-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4120/6288425/490ef8e1adf4/fpsyt-09-00659-g0002.jpg

相似文献

[1]
Antidepressants vs. Placebo for the Treatment of Functional Gastrointestinal Disorders in Adults: A Systematic Review and Meta-Analysis.

Front Psychiatry. 2018-12-4

[2]
Pharmacological interventions for somatoform disorders in adults.

Cochrane Database Syst Rev. 2014-11-7

[3]
Antidepressants versus placebo for panic disorder in adults.

Cochrane Database Syst Rev. 2018-4-5

[4]
Vortioxetine for depression in adults.

Cochrane Database Syst Rev. 2017-7-5

[5]
Pharmacological treatments in panic disorder in adults: a network meta-analysis.

Cochrane Database Syst Rev. 2023-11-28

[6]
Antidepressants for the treatment of depression in people with cancer.

Cochrane Database Syst Rev. 2018-4-23

[7]
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.

Cochrane Database Syst Rev. 2022-2-1

[8]
Antidepressants for the treatment of depression in people with cancer.

Cochrane Database Syst Rev. 2015-6-1

[9]
Antidepressants plus benzodiazepines for adults with major depression.

Cochrane Database Syst Rev. 2019-6-3

[10]
Antidepressants for people with epilepsy and depression.

Cochrane Database Syst Rev. 2021-4-16

引用本文的文献

[1]
Antidepressants in irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.

Ann Gastroenterol. 2025

[2]
The Causal Effects between Mood Swings and Gastrointestinal Diseases: A Mendelian Randomization Study.

Alpha Psychiatry. 2024-8-1

[3]
The causal role of multiple psycho-emotional disorders in gastroesophageal reflux disease: A two-sample Mendelian randomized study.

PLoS One. 2024

[4]
Feasibility, and barriers to use escitalopram in functional gastrointestinal disorders.

Front Pharmacol. 2023-5-22

[5]
Association between gastroesophageal reflux disease and depression disorder: A protocol for systematic review and meta-analysis.

Medicine (Baltimore). 2020-10-23

[6]
Shortcomings of Trials Assessing Antidepressants in the Management of Irritable Bowel Syndrome: A Critical Review.

J Clin Med. 2020-9-11

本文引用的文献

[1]
Management of Functional Somatic Syndromes and Bodily Distress.

Psychother Psychosom. 2018-1-6

[2]
Antidepressants for irritable bowel syndrome-A systematic review.

Pharmacol Rep. 2017-6-3

[3]
Centrally Targeted Pharmacotherapy for Chronic Abdominal Pain: Understanding and Management.

Handb Exp Pharmacol. 2017

[4]
Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction.

Gastroenterology. 2016-5

[5]
Functional dyspepsia: new insights into pathogenesis and therapy.

Korean J Intern Med. 2016-5

[6]
Imipramine for Treatment of Esophageal Hypersensitivity and Functional Heartburn: A Randomized Placebo-Controlled Trial.

Am J Gastroenterol. 2016-2

[7]
Efficacy of Mirtazapine in Patients With Functional Dyspepsia and Weight Loss.

Clin Gastroenterol Hepatol. 2016-3

[8]
Functional Dyspepsia.

N Engl J Med. 2015-11-5

[9]
[A clinical study of functional dyspepsia and mental disorder co-morbidity].

Zhonghua Nei Ke Za Zhi. 2015-6

[10]
Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis.

PLoS One. 2015-8-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索